World's Best Scientists 2026 revealed!
Vernice Jackson-Lewis

Vernice Jackson-Lewis

D-Index & Metrics

Neuroscience

D-Index
73
Citations
28775
World Ranking
2161
National Ranking
1028

Overview

Vernice Jackson-Lewis is a researcher affiliated with Columbia University in the United States. Their work focuses primarily on the fields of Medicine and Neuroscience, with specific attention to subfields such as Neurology, Genetics, and Cellular and Molecular Neuroscience.

The scientific topics covered in their research include Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, and Genetic Neurodegenerative Diseases. These themes reflect a concentration on neurodegenerative conditions and their underlying genetic and molecular mechanisms.

Jackson-Lewis has contributed to peer-reviewed scholarship with publications in notable venues. Their documented publication is titled Retromer dysfunction in amyotrophic lateral sclerosis, published in 2022 in the Proceedings of the National Academy of Sciences. This paper has accrued a citation count reflective of academic engagement.

In their research collaborations, Jackson-Lewis has frequently coauthored studies with several other scientists, including:

  • Matthew Harms
  • Hemali Phatnani
  • Eduardo Pérez-Torres
  • Irina Utkina-Sosunova
  • Vartika Mishra

The Proceedings of the National Academy of Sciences stands as the primary publication venue represented in their record, indicating participation in high-impact scientific discourse.

Best Publications

  • Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

    Du Chu Wu;Vernice Jackson-Lewis;Miquel Vila;Kim Tieu

  • Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.

    G T Liberatore;V Jackson-Lewis;S Vukosavic;A S Mandir

  • Protocol for the MPTP mouse model of Parkinson's disease

    Vernice Jackson-Lewis;Serge Przedborski

  • Oxidative stress and Parkinson’s disease

    Javier Blesa;Ines Trigo-Damas;Anna Quiroga-Varela;Vernice R. Jackson-Lewis

  • Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model

    Mingwei Li;Victor O. Ona;Christelle Guégan;Minghua Chen

  • Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

    Peter Teismann;Kim Tieu;Dong-Kug Choi;Du-Chu Wu

  • Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

    Serge Przedborski;Vernice Jackson-Lewis;Rina Yokoyama;Toshihiro Shibata

  • NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

    Du-Chu Wu;Peter Teismann;Kim Tieu;Miquel Vila

  • Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

    William Dauer;Nikolai Kholodilov;Miquel Vila;Anne Cecile Trillat

  • Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

    Vernice Jackson-Lewis;Michael Jakowec;Robert E Burke;Serge Przedborski

  • Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by instrastriatal injection of 6-hydroxydopamine

    S. Przedbroski;M. Leviver;M. Leviver;H. Jiang;M. Ferreira

  • Classic and New Animal Models of Parkinson's Disease

    Javier Blesa;Sudarshan Phani;Vernice Jackson-Lewis;Serge Przedborski

  • Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson’s disease

    Yanping Li;Wencheng Liu;Tinmarla F Oo;Lei Wang;Lei Wang

  • The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety

    Serge Przedborski;Vernice Jackson-Lewis;Ali B. Naini;Michael Jakowec

  • Bcl-2: Prolonging Life in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

    Vladimir Kostic;Vernice Jackson-Lewis;Fabienne de Bilbao;Michel Dubois-Dauphin

  • VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity

    Nobuyuki Takahashi;Lucinda L. Miner;Ichiro Sora;Hiroshi Ujike

  • Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

    S Przedborski;V Kostic;V Jackson-Lewis;AB Naini

  • Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

    Jahan Ara;Serge Przedborski;Ali B. Naini;Vernice Jackson-Lewis

  • Rapamycin Protects Against Neuron Death In in vitro and in vivo Models of Parkinson's Disease

    Cristina Malagelada;Zong Hao Jin;Vernice Jackson-Lewis;Serge Przedborski

  • Series Introduction: Neurodegeneration: What is it and where are we?

    Serge Przedborski;Miquel Vila;Vernice Jackson-Lewis

  • D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

    Kim Tieu;Celine Perier;Casper Caspersen;Peter Teismann

Frequent Co-Authors

Serge Przedborski
Serge Przedborski Columbia University
Robert E. Burke
Robert E. Burke Columbia University
Ted M. Dawson
Ted M. Dawson Johns Hopkins University School of Medicine
Valina L. Dawson
Valina L. Dawson Johns Hopkins University School of Medicine
David Sulzer
David Sulzer Columbia University
William T. Dauer
William T. Dauer The University of Texas Southwestern Medical Center
Richard J. Smeyne
Richard J. Smeyne Thomas Jefferson University
Nathan McDannold
Nathan McDannold Brigham and Women's Hospital
Christopher E. Henderson
Christopher E. Henderson Biogen (United States)
Michio Hirano
Michio Hirano Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Vernice Jackson-Lewis

Trending Scientists